Hong Kong · Biotechnology Research
Pharmaceuticals
Biotechnology
Healthcare
Biotechnology Research
Established in 2021 and headquartered in Hong Kong, China, GenEditBio is a gene therapy start-up company with an overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed “DNA surgery”) with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company’s core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticle (LNP) and engineered protein delivery vehicle (PDV). We have research laboratories and supporting offices in Hong Kong, Beijing, and Boston.
2021
Founded
Biotechnology Research
Industry
Hong Kong
Location
14,996,360
Ranking
20 employees
Size

Get full access to view complete information
